-
1
-
-
53049088208
-
Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19
-
COI: 1:CAS:528:DC%2BD1cXntFWmsrc%3D
-
Agrawal V, Huang N, Miller WL (2008) Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19. Pharmacogenet Genom 18:569–576. doi:10.1097/FPC.0b013e32830054ac
-
(2008)
Pharmacogenet Genom
, vol.18
, pp. 569-576
-
-
Agrawal, V.1
Huang, N.2
Miller, W.L.3
-
2
-
-
77957220642
-
Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase
-
COI: 1:CAS:528:DC%2BC3cXhtFKlsL3P
-
Agrawal V, Choi JH, Giacomini KM, Miller WL (2010) Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase. Pharmacogenet Genom 20:611–618. doi:10.1097/FPC.0b013e32833e0cb5
-
(2010)
Pharmacogenet Genom
, vol.20
, pp. 611-618
-
-
Agrawal, V.1
Choi, J.H.2
Giacomini, K.M.3
Miller, W.L.4
-
3
-
-
33846932361
-
The role of CYP2A6 in the emergence of nicotine dependence in adolescents
-
PID: 17130279
-
Audrain-McGovern J, Al Koudsi N, Rodriguez D, Wileyto EP, Shields PG, Tyndale RF (2007) The role of CYP2A6 in the emergence of nicotine dependence in adolescents. Pediatrics 119:e264–e274. doi:10.1542/peds.2006-1583
-
(2007)
Pediatrics
, vol.119
, pp. e264-e274
-
-
Audrain-McGovern, J.1
Al Koudsi, N.2
Rodriguez, D.3
Wileyto, E.P.4
Shields, P.G.5
Tyndale, R.F.6
-
4
-
-
84867868500
-
Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements
-
COI: 1:CAS:528:DC%2BC38XhsFWkurnE, PID: 22538991
-
Barrett LW, Fletcher S, Wilton SD (2012) Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. Cell Mol Life Sci 69:3613–3634. doi:10.1007/s00018-012-0990-9
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 3613-3634
-
-
Barrett, L.W.1
Fletcher, S.2
Wilton, S.D.3
-
5
-
-
84963774080
-
Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting
-
PID: 27083449
-
Ben Taleb Z, Ward KD, Asfar T, Jaber R, Auf R, Maziak W (2016) Predictors of nicotine withdrawal symptoms: findings from the first randomized smoking cessation trial in a low-income country setting. Int J Public Health. doi:10.1007/s00038-016-0818-8
-
(2016)
Int J Public Health
-
-
Ben Taleb, Z.1
Ward, K.D.2
Asfar, T.3
Jaber, R.4
Auf, R.5
Maziak, W.6
-
6
-
-
77953688842
-
Nicotine addiction
-
COI: 1:CAS:528:DC%2BC3cXnvVakurw%3D, PID: 20554984
-
Benowitz NL (2010) Nicotine addiction. N Engl J Med 362:2295–2303. doi:10.1056/NEJMra0809890
-
(2010)
N Engl J Med
, vol.362
, pp. 2295-2303
-
-
Benowitz, N.L.1
-
7
-
-
0142247254
-
Nicotine metabolite ratio as a predictor of cigarette consumption
-
COI: 1:CAS:528:DC%2BD3sXosVGisrk%3D, PID: 14577978
-
Benowitz NL, Pomerleau OF, Pomerleau CS, Jacob P 3rd (2003) Nicotine metabolite ratio as a predictor of cigarette consumption. Nicotine Tob Res 5:621–624. doi:10.1080/1462220031000158717
-
(2003)
Nicotine Tob Res
, vol.5
, pp. 621-624
-
-
Benowitz, N.L.1
Pomerleau, O.F.2
Pomerleau, C.S.3
Jacob, P.4
-
8
-
-
63849147368
-
Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol: 29–60
-
Benowitz NL, Hukkanen J, Jacob P, 3rd (2009) Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol: 29–60. doi: 10.1007/978-3-540-69248-5_2
-
(2009)
doi: 10.1007/978-3-540-69248-5_2
-
-
Benowitz, N.L.1
Hukkanen, J.2
Jacob, P.3
-
9
-
-
33644902914
-
Genetic architecture of smoking behavior: a study of Finnish adult twins
-
PID: 16611469
-
Broms U, Silventoinen K, Madden PA, Heath AC, Kaprio J (2006) Genetic architecture of smoking behavior: a study of Finnish adult twins. Twin Res Hum Genet 9:64–72. doi:10.1375/twin.9.1.64
-
(2006)
Twin Res Hum Genet
, vol.9
, pp. 64-72
-
-
Broms, U.1
Silventoinen, K.2
Madden, P.A.3
Heath, A.C.4
Kaprio, J.5
-
10
-
-
84874827328
-
CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers
-
COI: 1:CAS:528:DC%2BC3sXjtlykt7o%3D
-
Chenoweth MJ, O’Loughlin J, Sylvestre MP, Tyndale RF (2013) CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers. Pharmacogenet Genom 23:232–235. doi:10.1097/FPC.0b013e32835f834d
-
(2013)
Pharmacogenet Genom
, vol.23
, pp. 232-235
-
-
Chenoweth, M.J.1
O’Loughlin, J.2
Sylvestre, M.P.3
Tyndale, R.F.4
-
11
-
-
84907175878
-
Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers
-
COI: 1:CAS:528:DC%2BC2cXhsVyrsr7P
-
Chenoweth MJ, Novalen M, Hawk LW Jr, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF (2014a) Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiol Biomark Prev 23:1773–1782. doi:10.1158/1055-9965.epi-14-0427
-
(2014)
Cancer Epidemiol Biomark Prev
, vol.23
, pp. 1773-1782
-
-
Chenoweth, M.J.1
Novalen, M.2
Hawk, L.W.3
Schnoll, R.A.4
George, T.P.5
Cinciripini, P.M.6
Lerman, C.7
Tyndale, R.F.8
-
12
-
-
84894078170
-
Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158 K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption
-
COI: 1:CAS:528:DC%2BC2cXhs1ygt7w%3D
-
Chenoweth MJ, Zhu AZ, Sanderson Cox L, Ahluwalia JS, Benowitz NL, Tyndale RF (2014b) Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158 K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption. Pharmacogenet Genom 24:172–176. doi:10.1097/fpc.0000000000000031
-
(2014)
Pharmacogenet Genom
, vol.24
, pp. 172-176
-
-
Chenoweth, M.J.1
Zhu, A.Z.2
Sanderson Cox, L.3
Ahluwalia, J.S.4
Benowitz, N.L.5
Tyndale, R.F.6
-
13
-
-
84963799661
-
The nicotine metabolite ratio is associated with early smoking abstinence even after controlling for factors that influence the nicotine metabolite ratio
-
PID: 26069034
-
Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW Jr, George TP, Cinciripini PM, Lerman C, Tyndale RF (2016) The nicotine metabolite ratio is associated with early smoking abstinence even after controlling for factors that influence the nicotine metabolite ratio. Nicotine Tob Res 18:491–495. doi:10.1093/ntr/ntv125
-
(2016)
Nicotine Tob Res
, vol.18
, pp. 491-495
-
-
Chenoweth, M.J.1
Schnoll, R.A.2
Novalen, M.3
Hawk, L.W.4
George, T.P.5
Cinciripini, P.M.6
Lerman, C.7
Tyndale, R.F.8
-
14
-
-
80052922074
-
The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients
-
PID: 21770725
-
de Jonge H, Metalidis C, Naesens M, Lambrechts D, Kuypers DR (2011) The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients. Pharmacogenomics 12:1281–1291. doi:10.2217/pgs.11.77
-
(2011)
Pharmacogenomics
, vol.12
, pp. 1281-1291
-
-
de Jonge, H.1
Metalidis, C.2
Naesens, M.3
Lambrechts, D.4
Kuypers, D.R.5
-
15
-
-
84855975450
-
Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking
-
COI: 1:CAS:528:DC%2BC38XnsleltQ%3D%3D
-
Dobrinas M, Cornuz J, Pedrido L, Eap CB (2012) Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking. Pharmacogenet Genom 22:143–151. doi:10.1097/FPC.0b013e32834e9e1a
-
(2012)
Pharmacogenet Genom
, vol.22
, pp. 143-151
-
-
Dobrinas, M.1
Cornuz, J.2
Pedrido, L.3
Eap, C.B.4
-
16
-
-
84952690609
-
Cytochrome P450 oxidoreductase influences CYP2B6 activity in cyclophosphamide bioactivation
-
PID: 26544874
-
El-Serafi I, Afsharian P, Moshfegh A, Hassan M, Terelius Y (2015) Cytochrome P450 oxidoreductase influences CYP2B6 activity in cyclophosphamide bioactivation. PLoS One 10:e0141979. doi:10.1371/journal.pone.0141979
-
(2015)
PLoS One
, vol.10
-
-
El-Serafi, I.1
Afsharian, P.2
Moshfegh, A.3
Hassan, M.4
Terelius, Y.5
-
17
-
-
66849098131
-
Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation
-
COI: 1:CAS:528:DC%2BD1MXkslGnur0%3D, PID: 19374516
-
Gomes AM, Winter S, Klein K, Turpeinen M, Schaeffeler E, Schwab M, Zanger UM (2009) Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation. Pharmacogenomics 10:579–599. doi:10.2217/pgs.09.7
-
(2009)
Pharmacogenomics
, vol.10
, pp. 579-599
-
-
Gomes, A.M.1
Winter, S.2
Klein, K.3
Turpeinen, M.4
Schaeffeler, E.5
Schwab, M.6
Zanger, U.M.7
-
18
-
-
84871535052
-
Tobacco smoking, quitting, and relapsing among adult males in Mainland China: the China seven cities study
-
PID: 22581939
-
Gruder CL, Trinidad DR, Palmer PH, Xie B, Li L, Johnson CA (2013) Tobacco smoking, quitting, and relapsing among adult males in Mainland China: the China seven cities study. Nicotine Tob Res 15:223–230. doi:10.1093/ntr/nts116
-
(2013)
Nicotine Tob Res
, vol.15
, pp. 223-230
-
-
Gruder, C.L.1
Trinidad, D.R.2
Palmer, P.H.3
Xie, B.4
Li, L.5
Johnson, C.A.6
-
19
-
-
0038507099
-
Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase
-
COI: 1:CAS:528:DC%2BD3sXlt1Clsb4%3D, PID: 12697746
-
Gu J, Weng Y, Zhang QY, Cui H, Behr M, Wu L, Yang W, Zhang L, Ding X (2003) Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J Biol Chem 278:25895–25901. doi:10.1074/jbc.M303125200
-
(2003)
J Biol Chem
, vol.278
, pp. 25895-25901
-
-
Gu, J.1
Weng, Y.2
Zhang, Q.Y.3
Cui, H.4
Behr, M.5
Wu, L.6
Yang, W.7
Zhang, L.8
Ding, X.9
-
20
-
-
0037527821
-
Electron transfer in human cytochrome P450 reductase
-
COI: 1:CAS:528:DC%2BD3sXktF2isL4%3D, PID: 12773143
-
Gutierrez A, Grunau A, Paine M, Munro AW, Wolf CR, Roberts GC, Scrutton NS (2003) Electron transfer in human cytochrome P450 reductase. Biochem Soc Trans 31:497–501. doi:10.1042/bst0310497
-
(2003)
Biochem Soc Trans
, vol.31
, pp. 497-501
-
-
Gutierrez, A.1
Grunau, A.2
Paine, M.3
Munro, A.W.4
Wolf, C.R.5
Roberts, G.C.6
Scrutton, N.S.7
-
21
-
-
33749640220
-
Genetic correlations between smoking initiation and smoking behaviors in a twin sample
-
PID: 16675152
-
Hardie TL, Moss HB, Lynch KG (2006) Genetic correlations between smoking initiation and smoking behaviors in a twin sample. Addict Behav 31:2030–2037. doi:10.1016/j.addbeh.2006.02.010
-
(2006)
Addict Behav
, vol.31
, pp. 2030-2037
-
-
Hardie, T.L.1
Moss, H.B.2
Lynch, K.G.3
-
22
-
-
44349094918
-
P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity
-
COI: 1:CAS:528:DC%2BD1cXltVWmtL4%3D, PID: 18433346
-
Hart SN, Zhong XB (2008) P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity. Expert Opin Drug Metab Toxicol 4:439–452. doi:10.1517/17425255.4.4.439
-
(2008)
Expert Opin Drug Metab Toxicol
, vol.4
, pp. 439-452
-
-
Hart, S.N.1
Zhong, X.B.2
-
23
-
-
38549085263
-
Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism
-
COI: 1:CAS:528:DC%2BD1cXmt1aqsw%3D%3D
-
Hart SN, Wang S, Nakamoto K, Wesselman C, Li Y, Zhong XB (2008) Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism. Pharmacogenet Genom 18:11–24. doi:10.1097/FPC.0b013e3282f2f121
-
(2008)
Pharmacogenet Genom
, vol.18
, pp. 11-24
-
-
Hart, S.N.1
Wang, S.2
Nakamoto, K.3
Wesselman, C.4
Li, Y.5
Zhong, X.B.6
-
24
-
-
84963491067
-
Evaluation of biological, psychosocial, and interventional predictors for success of a smoking cessation programme in Hong Kong
-
COI: 1:STN:280:DC%2BC28vjtFShtA%3D%3D, PID: 26586081
-
Ho KS, Choi BW, Chan H, Ching KW (2016) Evaluation of biological, psychosocial, and interventional predictors for success of a smoking cessation programme in Hong Kong. Hong Kong Med J 22:158–164. doi:10.12809/hkmj154549
-
(2016)
Hong Kong Med J
, vol.22
, pp. 158-164
-
-
Ho, K.S.1
Choi, B.W.2
Chan, H.3
Ching, K.W.4
-
25
-
-
84867553855
-
Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy
-
COI: 1:CAS:528:DC%2BC38XhsVKgsrrL
-
Hu L, Zhuo W, He YJ, Zhou HH, Fan L (2012) Pharmacogenetics of P450 oxidoreductase: implications in drug metabolism and therapy. Pharmacogenet Genom 22:812–819. doi:10.1097/FPC.0b013e328358d92b
-
(2012)
Pharmacogenet Genom
, vol.22
, pp. 812-819
-
-
Hu, L.1
Zhuo, W.2
He, Y.J.3
Zhou, H.H.4
Fan, L.5
-
26
-
-
20244367932
-
Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis
-
COI: 1:CAS:528:DC%2BD2MXjs12rt7o%3D, PID: 15793702
-
Huang N, Pandey AV, Agrawal V, Reardon W, Lapunzina PD, Mowat D, Jabs EW, Van Vliet G, Sack J, Fluck CE, Miller WL (2005) Diversity and function of mutations in P450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidogenesis. Am J Hum Genet 76:729–749. doi:10.1086/429417
-
(2005)
Am J Hum Genet
, vol.76
, pp. 729-749
-
-
Huang, N.1
Pandey, A.V.2
Agrawal, V.3
Reardon, W.4
Lapunzina, P.D.5
Mowat, D.6
Jabs, E.W.7
Van Vliet, G.8
Sack, J.9
Fluck, C.E.10
Miller, W.L.11
-
27
-
-
40349092943
-
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations
-
COI: 1:CAS:528:DC%2BD1cXhvFalsLc%3D, PID: 18230729
-
Huang N, Agrawal V, Giacomini KM, Miller WL (2008) Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci USA 105:1733–1738. doi:10.1073/pnas.0711621105
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 1733-1738
-
-
Huang, N.1
Agrawal, V.2
Giacomini, K.M.3
Miller, W.L.4
-
28
-
-
84983097844
-
Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation
-
COI: 1:CAS:528:DC%2BC2MXitVyru77I
-
Lv J, Hu L, Zhuo W, Zhang C, Zhou H, Fan L (2016) Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation. Pharmacogenet Genom 26:80–87. doi:10.1097/fpc.0000000000000190
-
(2016)
Pharmacogenet Genom
, vol.26
, pp. 80-87
-
-
Lv, J.1
Hu, L.2
Zhuo, W.3
Zhang, C.4
Zhou, H.5
Fan, L.6
-
29
-
-
18844367746
-
Minireview: regulation of steroidogenesis by electron transfer
-
COI: 1:CAS:528:DC%2BD2MXksleitbg%3D, PID: 15774560
-
Miller WL (2005) Minireview: regulation of steroidogenesis by electron transfer. Endocrinology 146:2544–2550. doi:10.1210/en.2005-0096
-
(2005)
Endocrinology
, vol.146
, pp. 2544-2550
-
-
Miller, W.L.1
-
30
-
-
59649124443
-
Genetic variation in human P450 oxidoreductase
-
COI: 1:CAS:528:DC%2BD1MXitVOls7g%3D, PID: 18930113
-
Miller WL, Huang N, Agrawal V, Giacomini KM (2009) Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 300:180–184. doi:10.1016/j.mce.2008.09.017
-
(2009)
Mol Cell Endocrinol
, vol.300
, pp. 180-184
-
-
Miller, W.L.1
Huang, N.2
Agrawal, V.3
Giacomini, K.M.4
-
31
-
-
79952068290
-
Consequences of POR mutations and polymorphisms
-
COI: 1:CAS:528:DC%2BC3MXjsFCnt7k%3D, PID: 21070833
-
Miller WL, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM (2011) Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 336:174–179. doi:10.1016/j.mce.2010.10.022
-
(2011)
Mol Cell Endocrinol
, vol.336
, pp. 174-179
-
-
Miller, W.L.1
Agrawal, V.2
Sandee, D.3
Tee, M.K.4
Huang, N.5
Choi, J.H.6
Morrissey, K.7
Giacomini, K.M.8
-
32
-
-
84929497683
-
Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium
-
PID: 25896935
-
Mons U, Muezzinler A, Gellert C, Schottker B, Abnet CC et al (2015) Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ 350:h1551. doi:10.1136/bmj.h1551
-
(2015)
BMJ
, vol.350
, pp. h1551
-
-
Mons, U.1
Muezzinler, A.2
Gellert, C.3
Schottker, B.4
Abnet, C.C.5
-
34
-
-
77957844107
-
Trends in smoking and quitting in China from 1993 to 2003: national Health Service Survey data
-
PID: 20931062
-
Qian J, Cai M, Gao J, Tang S, Xu L, Critchley JA (2010) Trends in smoking and quitting in China from 1993 to 2003: national Health Service Survey data. Bull World Health Organ 88:769–776. doi:10.2471/BLT.09.064709
-
(2010)
Bull World Health Organ
, vol.88
, pp. 769-776
-
-
Qian, J.1
Cai, M.2
Gao, J.3
Tang, S.4
Xu, L.5
Critchley, J.A.6
-
35
-
-
79952746153
-
Genetic polymorphisms and haplotypes of POR, encoding cytochrome P450 oxidoreductase, in a Japanese population
-
COI: 1:CAS:528:DC%2BC3MXls1Ortbk%3D, PID: 21084761
-
Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima-Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada J, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura T (2011) Genetic polymorphisms and haplotypes of POR, encoding cytochrome P450 oxidoreductase, in a Japanese population. Drug Metab Pharmacokinet 26:107–116. doi:10.2133/dmpk.DMPK-10-SC-096
-
(2011)
Drug Metab Pharmacokinet
, vol.26
, pp. 107-116
-
-
Saito, Y.1
Yamamoto, N.2
Katori, N.3
Maekawa, K.4
Fukushima-Uesaka, H.5
Sugimoto, D.6
Kurose, K.7
Sai, K.8
Kaniwa, N.9
Sawada, J.10
Kunitoh, H.11
Ohe, Y.12
Yoshida, T.13
Matsumura, Y.14
Saijo, N.15
Okuda, H.16
Tamura, T.17
-
36
-
-
77958581296
-
Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro
-
COI: 1:CAS:528:DC%2BC3cXht1yrsr3L
-
Sandee D, Morrissey K, Agrawal V, Tam HK, Kramer MA, Tracy TS, Giacomini KM, Miller WL (2010) Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro. Pharmacogenet Genom 20:677–686. doi:10.1097/FPC.0b013e32833f4f9b
-
(2010)
Pharmacogenet Genom
, vol.20
, pp. 677-686
-
-
Sandee, D.1
Morrissey, K.2
Agrawal, V.3
Tam, H.K.4
Kramer, M.A.5
Tracy, T.S.6
Giacomini, K.M.7
Miller, W.L.8
-
37
-
-
58549112185
-
Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study
-
COI: 1:CAS:528:DC%2BD1MXhtlOmtLc%3D, PID: 19000709
-
Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C (2009) Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacol Biochem Behav 92:6–11. doi:10.1016/j.pbb.2008.10.016
-
(2009)
Pharmacol Biochem Behav
, vol.92
, pp. 6-11
-
-
Schnoll, R.A.1
Patterson, F.2
Wileyto, E.P.3
Tyndale, R.F.4
Benowitz, N.5
Lerman, C.6
-
38
-
-
84902179345
-
The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race
-
COI: 1:CAS:528:DC%2BC2cXksFWguw%3D%3D, PID: 24402139
-
Schnoll RA, George TP, Hawk L, Cinciripini P, Wileyto P, Tyndale RF (2014) The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology 231:2515–2523. doi:10.1007/s00213-013-3421-1
-
(2014)
Psychopharmacology
, vol.231
, pp. 2515-2523
-
-
Schnoll, R.A.1
George, T.P.2
Hawk, L.3
Cinciripini, P.4
Wileyto, P.5
Tyndale, R.F.6
-
39
-
-
43749123253
-
Genetic and clinical features of P450 oxidoreductase deficiency
-
COI: 1:CAS:528:DC%2BD1cXlvV2qsrg%3D, PID: 18259105
-
Scott RR, Miller WL (2008) Genetic and clinical features of P450 oxidoreductase deficiency. Horm Res 69:266–275. doi:10.1159/000114857
-
(2008)
Horm Res
, vol.69
, pp. 266-275
-
-
Scott, R.R.1
Miller, W.L.2
-
40
-
-
34347219795
-
Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency
-
COI: 1:CAS:528:DC%2BD2sXmslOgsL0%3D, PID: 17389698
-
Scott RR, Gomes LG, Huang N, Van Vliet G, Miller WL (2007) Apparent manifesting heterozygosity in P450 oxidoreductase deficiency and its effect on coexisting 21-hydroxylase deficiency. J Clin Endocrinol Metab 92:2318–2322. doi:10.1210/jc.2006-2345
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 2318-2322
-
-
Scott, R.R.1
Gomes, L.G.2
Huang, N.3
Van Vliet, G.4
Miller, W.L.5
-
41
-
-
84859775647
-
Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine
-
COI: 1:CAS:528:DC%2BC38Xls1Wis7g%3D, PID: 22334123
-
Sofuoglu M, Herman AI, Nadim H, Jatlow P (2012) Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotine. Neuropsychopharmacology 37:1509–1516. doi:10.1038/npp.2011.336
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 1509-1516
-
-
Sofuoglu, M.1
Herman, A.I.2
Nadim, H.3
Jatlow, P.4
-
42
-
-
80055091500
-
Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan
-
COI: 1:CAS:528:DC%2BC3MXhs1GqtL7N, PID: 21791872
-
Tamaki Y, Arai T, Sugimura H, Sasaki T, Honda M, Muroi Y, Matsubara Y, Kanno S, Ishikawa M, Hirasawa N, Hiratsuka M (2011) Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan. Drug Metab Pharmacokinet 26:516–522. doi:10.2133/dmpk.DMPK-11-RG-046
-
(2011)
Drug Metab Pharmacokinet
, vol.26
, pp. 516-522
-
-
Tamaki, Y.1
Arai, T.2
Sugimura, H.3
Sasaki, T.4
Honda, M.5
Muroi, Y.6
Matsubara, Y.7
Kanno, S.8
Ishikawa, M.9
Hirasawa, N.10
Hiratsuka, M.11
-
43
-
-
84997525281
-
Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies
-
PID: 27097748
-
van Osch FH, Jochems SH, van Schooten FJ, Bryan RT, Zeegers MP (2016) Quantified relations between exposure to tobacco smoking and bladder cancer risk: a meta-analysis of 89 observational studies. Int J Epidemiol. doi:10.1093/ije/dyw044
-
(2016)
Int J Epidemiol
-
-
van Osch, F.H.1
Jochems, S.H.2
van Schooten, F.J.3
Bryan, R.T.4
Zeegers, M.P.5
-
44
-
-
84946595623
-
The nicotine metabolite ratio in pregnancy measured by trans-3′-hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation
-
PID: 25589677
-
Vaz LR, Coleman T, Cooper S, Aveyard P, Leonardi-Bee J, SNAP trial team (2015) The nicotine metabolite ratio in pregnancy measured by trans-3′-hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine Tob Res 17:1318–1323. doi:10.1093/ntr/ntu342
-
(2015)
Nicotine Tob Res
, vol.17
, pp. 1318-1323
-
-
Vaz, L.R.1
Coleman, T.2
Cooper, S.3
Aveyard, P.4
Leonardi-Bee, J.5
SNAP trial team6
-
45
-
-
84867603666
-
CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Delta5′(1′) iminium ion
-
von Weymarn LB, Retzlaff C, Murphy SE (2012) CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Delta5′(1′) iminium ion. J Pharmacol Exp Ther 343:307–315. doi:10.1124/jpet.112.195255
-
(2012)
J Pharmacol Exp Ther
, vol.343
, pp. 307-315
-
-
von Weymarn, L.B.1
Retzlaff, C.2
Murphy, S.E.3
-
46
-
-
80052681515
-
Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk
-
COI: 1:CAS:528:DC%2BC3MXhtFKisbjM, PID: 21747048
-
Wassenaar CA, Dong Q, Wei Q, Amos CI, Spitz MR, Tyndale RF (2011) Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst 103:1342–1346. doi:10.1093/jnci/djr237
-
(2011)
J Natl Cancer Inst
, vol.103
, pp. 1342-1346
-
-
Wassenaar, C.A.1
Dong, Q.2
Wei, Q.3
Amos, C.I.4
Spitz, M.R.5
Tyndale, R.F.6
-
47
-
-
84991380161
-
-
World Health Organization (1998) Guidelines for controlling and monitoring the tobacco epidemic
-
World Health Organization (1998) Guidelines for controlling and monitoring the tobacco epidemic
-
-
-
-
48
-
-
84979920294
-
WHO report on the global tobacco epidemic
-
World Health Organization (2015) WHO report on the global tobacco epidemic, 2015: Raising taxes on tobacco
-
(2015)
2015: Raising taxes on tobacco
-
-
-
49
-
-
19944426178
-
reductase gene: effects on development, reproduction, and microsomal cytochrome P450
-
COI: 1:CAS:528:DC%2BD2MXhtVWmtrg%3D, PID: 15328377
-
reductase gene: effects on development, reproduction, and microsomal cytochrome P450. J Pharmacol Exp Ther 312:35–43. doi:10.1124/jpet.104.073353
-
(2005)
J Pharmacol Exp Ther
, vol.312
, pp. 35-43
-
-
Wu, L.1
Gu, J.2
Cui, H.3
Zhang, Q.Y.4
Behr, M.5
Fang, C.6
Weng, Y.7
Kluetzman, K.8
Swiatek, P.J.9
Yang, W.10
Kaminsky, L.11
Ding, X.12
-
50
-
-
0038036814
-
The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit
-
COI: 1:CAS:528:DC%2BD3sXjtlGnuro%3D, PID: 12745498
-
Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR, Eisen SA (2003) The heritability of failed smoking cessation and nicotine withdrawal in twins who smoked and attempted to quit. Nicotine Tob Res 5:245–254. doi:10.1080/1462220031000073667
-
(2003)
Nicotine Tob Res
, vol.5
, pp. 245-254
-
-
Xian, H.1
Scherrer, J.F.2
Madden, P.A.3
Lyons, M.J.4
Tsuang, M.5
True, W.R.6
Eisen, S.A.7
-
51
-
-
14944356888
-
Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders
-
PID: 15841876
-
Xian H, Scherrer JF, Madden PA, Lyons MJ, Tsuang M, True WR, Eisen SA (2005) Latent class typology of nicotine withdrawal: genetic contributions and association with failed smoking cessation and psychiatric disorders. Psychol Med 35:409–419. doi:10.1017/S0033291704003289
-
(2005)
Psychol Med
, vol.35
, pp. 409-419
-
-
Xian, H.1
Scherrer, J.F.2
Madden, P.A.3
Lyons, M.J.4
Tsuang, M.5
True, W.R.6
Eisen, S.A.7
-
52
-
-
84934777303
-
Functional POR A503V is associated with the risk of bladder cancer in a Chinese population
-
PID: 26123203
-
Xiao X, Ma G, Li S, Wang M, Liu N, Ma L, Zhang Z, Chu H, Wang SL (2015) Functional POR A503V is associated with the risk of bladder cancer in a Chinese population. Sci Rep 5:11751. doi:10.1038/srep11751
-
(2015)
Sci Rep
, vol.5
, pp. 11751
-
-
Xiao, X.1
Ma, G.2
Li, S.3
Wang, M.4
Liu, N.5
Ma, L.6
Zhang, Z.7
Chu, H.8
Wang, S.L.9
-
53
-
-
79960027848
-
Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity
-
COI: 1:CAS:528:DC%2BC3MXoslWrsLg%3D, PID: 21596114
-
Xue X, Gong L, Qi X, Wu Y, Xing G, Yao J, Luan Y, Xiao Y, Li Y, Wu X, Chen M, Gu J, Ren J (2011) Knockout of hepatic P450 reductase aggravates triptolide-induced toxicity. Toxicol Lett 205:47–54. doi:10.1016/j.toxlet.2011.05.003
-
(2011)
Toxicol Lett
, vol.205
, pp. 47-54
-
-
Xue, X.1
Gong, L.2
Qi, X.3
Wu, Y.4
Xing, G.5
Yao, J.6
Luan, Y.7
Xiao, Y.8
Li, Y.9
Wu, X.10
Chen, M.11
Gu, J.12
Ren, J.13
-
55
-
-
83455225481
-
Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men
-
COI: 1:CAS:528:DC%2BC3MXhs1CjtLjL, PID: 22177374
-
Yang GFZ, Chen X, Yuan H, Yang H, Huang Y, Ouyang D, Tan Z, Tan H, Huang Z, Zhou H (2011) Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men. Clin Ther 33:2060–2070. doi:10.1016/j.clinthera.2011.11.004
-
(2011)
Clin Ther
, vol.33
, pp. 2060-2070
-
-
Yang, G.F.Z.1
Chen, X.2
Yuan, H.3
Yang, H.4
Huang, Y.5
Ouyang, D.6
Tan, Z.7
Tan, H.8
Huang, Z.9
Zhou, H.10
-
56
-
-
84958891764
-
Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study
-
COI: 1:CAS:528:DC%2BC28XhtFWiu7g%3D, PID: 26662855
-
Yuan JM, Nelson HH, Butler LM, Carmella SG, Wang R, Kuriger-Laber JK, Adams-Haduch J, Hecht SS, Gao YT, Murphy SE (2016) Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study. Int J Cancer 138:2161–2171. doi:10.1002/ijc.29963
-
(2016)
Int J Cancer
, vol.138
, pp. 2161-2171
-
-
Yuan, J.M.1
Nelson, H.H.2
Butler, L.M.3
Carmella, S.G.4
Wang, R.5
Kuriger-Laber, J.K.6
Adams-Haduch, J.7
Hecht, S.S.8
Gao, Y.T.9
Murphy, S.E.10
-
57
-
-
79960616137
-
Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose
-
COI: 1:CAS:528:DC%2BC3MXps1yqtLc%3D, PID: 21562147
-
Zhang X, Li L, Ding X, Kaminsky LS (2011) Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose. Drug Metab Dispos 39:1433–1439. doi:10.1124/dmd.111.038836
-
(2011)
Drug Metab Dispos
, vol.39
, pp. 1433-1439
-
-
Zhang, X.1
Li, L.2
Ding, X.3
Kaminsky, L.S.4
-
58
-
-
84876737381
-
Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers
-
PID: 23097010
-
Zhang JJ, Zhang H, Ding XL, Ma S, Miao LY (2013) Effect of the P450 oxidoreductase 28 polymorphism on the pharmacokinetics of tacrolimus in Chinese healthy male volunteers. Eur J Clin Pharmacol 69:807–812. doi:10.1007/s00228-012-1432-1
-
(2013)
Eur J Clin Pharmacol
, vol.69
, pp. 807-812
-
-
Zhang, J.J.1
Zhang, H.2
Ding, X.L.3
Ma, S.4
Miao, L.Y.5
|